Avenue Therapeutics (NASDAQ:ATXI) Shares Set to Reverse Split on Friday, April 26th

Avenue Therapeutics, Inc. (NASDAQ:ATXI)’s stock is scheduled to reverse split on Friday, April 26th. The 1-75 reverse split was announced on Friday, April 26th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, April 26th.

Avenue Therapeutics Price Performance

Avenue Therapeutics stock traded down $0.04 during mid-day trading on Wednesday, reaching $0.09. 12,284,611 shares of the company were exchanged, compared to its average volume of 4,543,282. The company has a fifty day simple moving average of $0.15 and a 200-day simple moving average of $0.21. Avenue Therapeutics has a 12 month low of $0.09 and a 12 month high of $1.25. The firm has a market cap of $4.17 million, a PE ratio of -0.07 and a beta of -0.24.

Avenue Therapeutics (NASDAQ:ATXI) last issued its earnings results on Monday, March 18th. The company reported $0.56 earnings per share for the quarter.

Avenue Therapeutics Company Profile

Avenue Therapeutics, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders.